The Scientist

» workplace and disease/medicine

Most Recent

image: Stem Cell Trial Nearly Approved

Stem Cell Trial Nearly Approved

By | February 15, 2013

The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.


image: Stem Cells: Safe Haven For TB

Stem Cells: Safe Haven For TB

By | February 5, 2013

Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.


image: Opinion: Health Booth 2020

Opinion: Health Booth 2020

By | February 4, 2013

Using a SMART card containing your genetic information and medical history, you could one day soon be diagnosed and treated for all kinds of diseases at an ATM-style kiosk.


image: A Chill Issue

A Chill Issue

By | February 1, 2013

The very cold, the merely chilled, and the colorful


image: Cholera Confusion, circa 1832

Cholera Confusion, circa 1832

By | February 1, 2013

As cholera first tore through the Europe in the mid-19th century, people tried anything to prevent the deadly disease. Then science stepped in.


image: Immune to Failure

Immune to Failure

By | February 1, 2013

With dogged persistence and an unwillingness to entertain defeat, Bruce Beutler discovered a receptor that powers the innate immune response to infections—and earned his share of a Nobel Prize.


image: Catching the Cold

Catching the Cold

By | February 1, 2013

Tracking the genetic diversity and evolution of rhinoviruses can lead to a better understanding of viral evolution, the common cold, and more dangerous infections.


image: Opinion: An Explosion of Devices

Opinion: An Explosion of Devices

By | January 28, 2013

From cardiovascular problems to neurological disorders, a plethora of new medical devices are reducing the need for surgery and improving the quality and safety of healthcare.


image: Stem Cells Not Rejected

Stem Cells Not Rejected

By | January 25, 2013

Researchers uncover more evidence that reprogrammed stem cells are not attacked by the immune system, suggesting they may one day serve as effective therapies.

1 Comment

image: Non-coding Mutations May Drive Cancer

Non-coding Mutations May Drive Cancer

By | January 24, 2013

The majority of human melanomas contain mutations in a gene promoter, suggesting mutations in regulatory regions may spur some cancers.


Popular Now

  1. Birth of the Skin Microbiome
    Daily News Birth of the Skin Microbiome

    The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

  2. Inside a Lab Mouse’s High-Fat Diet
  3. Battling the Bulge
    Bio Business Battling the Bulge

    Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

  4. How Gastric Bypass Can Kill Sugar Cravings
Life Technologies